Archives
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride): Practical Protocol and Workflow Guide
What This Product Solves
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride, CAS 25952-53-8) is a water-soluble carbodiimide reagent that facilitates direct amide bond formation between carboxyl and primary amine groups in aqueous solution. It solves a major bottleneck in peptide synthesis and bioconjugation by enabling coupling reactions under mild, aqueous conditions, thereby reducing the need for organic solvents and minimizing undesired side reactions. EDC.HCl is also utilized as a nucleotide synthesis reagent and finds application in esterification and lactonization protocols. Use of this reagent is strictly limited to in vitro workflows, as no in vivo or clinical performance data are available.
Protocol Parameters
- Solubility in Water | ≥39 mg/mL | Stock solution preparation and aqueous coupling reactions | Ensures preparation of concentrated, homogenous stock solutions for peptide synthesis and bioconjugation | product information
- Storage Condition | -20°C, desiccated (solid form) | Long-term reagent stability | Prevents hydrolysis and decomposition; avoids loss of activity during storage | product information
- Working Solution Stability | Use immediately; avoid long-term storage of solutions | Routine amide bond formation workflows | EDC.HCl solutions are prone to hydrolysis; fresh preparation ensures consistent coupling efficiency | product information
- Solubility in DMSO | ≥19.2 mg/mL | Alternative solvent systems for poorly water-soluble substrates | Enables use in workflows requiring organic co-solvents | product information
- Carbodiimide Quantification | Spectrophotometric monitoring | Real-time or endpoint reaction monitoring | Quantitative assessment of EDC.HCl consumption and byproduct formation | product information
Workflow Setup and QC Checklist
- Stock Solution Preparation: Dissolve EDC.HCl in water, DMSO, or ethanol at concentrations up to the solubility limits specified above. Prepare solutions fresh prior to use to avoid hydrolysis.
- Reagent Handling: Minimize exposure to ambient moisture and temperature fluctuations. Dispense from the solid desiccated stock stored at -20°C. Use desiccators and rapid weighing procedures as standard.
- Coupling Reaction Setup: Combine activated carboxyl-containing substrate and primary amine in buffered aqueous solution. Add EDC.HCl immediately before initiating the reaction. Optimize buffer pH (typically pH 4.5–7.5, per standard peptide synthesis best practices) based on substrate properties.
- Monitoring and Termination: Monitor reaction progress using spectrophotometric or chromatographic methods. Terminate the reaction by quenching excess reagent or adjusting pH as required by the downstream workflow.
- Quality Control: Confirm product formation and absence of residual carbodiimide by LC/MS, HPLC, or gel-based analysis as appropriate.
Common Failure Modes and Fixes
- Low Coupling Efficiency: Can result from degraded or hydrolyzed EDC.HCl. Always use freshly prepared solutions and confirm storage at -20°C desiccated. If persistent, check substrate purity and pH conditions.
- Precipitation or Cloudiness: May indicate incomplete dissolution or incompatibility with the solvent system. Verify solubility limits and adjust solvent composition (e.g., increase water content or use compatible organic co-solvent).
- Side Product Formation: Overactivation or prolonged reaction times can lead to N-acylurea or O-acylisourea byproducts. Shorten reaction times, optimize reagent stoichiometry, and fine-tune pH to minimize side reactions.
- Inconsistent Results Between Batches: May result from improper storage or handling. Standardize all reagent preparation and handling steps, and implement batch-specific QC checks.
Scope and Limitations
EDC.HCl is validated for in vitro applications such as peptide synthesis, protein/peptide bioconjugation, nucleotide coupling, esterification, and lactonization. Its water solubility is advantageous for workflows requiring aqueous conditions. However, the use of EDC.HCl in in vivo or clinical settings is not supported due to the absence of relevant data. Solution stability is limited, and activity can be compromised by prolonged exposure to moisture or elevated temperatures. For any workflow outside the listed applications or for protocols involving living systems, alternative validated reagents are recommended.
Additional technical information and protocol discussion can be found in internal articles, such as EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine HCl): Technical Use and Protocol Parameters, which details in vitro coupling guidance, and Practical Use of EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine HCl), which expands on workflow parameters and in vitro boundaries.
Conclusion
When used according to best practices, EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) provides a robust, water-soluble solution for amide bond formation in peptide synthesis, bioconjugation, and nucleotide coupling. Strict adherence to solubility, storage, and handling protocols is essential for consistent, high-yield reactions. For the latest specifications and ordering, refer to the EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) product page at APExBIO.